Illinois CHICAGO and NASHVILLE, Tenn., May 13, 2022 /PRNewswire/ --. CHICAGO, Jan. 26, 2022 /PRNewswire/ -- GTCR, a leading private equity firm founded in 1980, today announced the recent closing of its first Strategic Growth Fund with $2 .0 billion of limited. Over the past 31 years, Biocoat has developed a diverse base of both blue-chip and emerging medical device customers, a highly experienced team of engineers and scientists, and state-of-the-art manufacturing and R&D facilities. "Jim Moran and the Biocoat team have built an exciting platform company," said Chip Hance. Park Place Technologies is an IT company that provided organizations around the globe with post-warranty maintenance and support solutions. Ironshore Insurance provides broker-sourced specialty property and casualty insurance coverages for varying risks. Dr. Davis said "We are thrilled to announce this recapitalization with GTCR as our new majority shareholder and partner. GTCR has raised 1 round. We look forward to supporting Chip, Jim, and the Biocoat team as the Company continues its aggressive pursuit of follow-on acquisitions in the next chapter of its growth.". CHICAGO & NEW YORK--(BUSINESS WIRE)--GTCR LLC and Blackstone (NYSE:BX) today jointly announced a new partnership in which funds managed by Blackstones GP Stakes business will acquire a minority ownership interest in GTCR. About GTCR Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Healthcare, Financial Services & Technology, Technology, Media . Customer Service. GTCR is based in Chicago with offices in New York and West Palm Beach. Switchboard: +1 (212) 583-5000. For press inquiries, contact[emailprotected]. Onze We are sorry for the inconvenience. For press inquiries, contact [emailprotected]. Get the full list, Morningstar Institutional Equity Research, Co-Chief Executive Officer & Managing Director, Chief Financial Officer & Managing Director, Chief Information Security Officer & Managing Director, Managing Director and Co-Head of Healthcare. Blackstone Contact: As part of GTCR's Leaders Strategy, Dave King, the former Chairman and CEO of Labcorp, will join the PathGroup Board as Chairman, partnering with Dr. Davis and GTCR to further invest in PathGroup's capabilities across the pathology, molecular, and genetic diagnostics modalities. Paula Chirhart "Jim Moran and the Biocoat team have built an exciting platform company," said Chip Hance. The Company is focused on developing highly technical, customized coating formulations critical to medical device performance. Finally, we have a talented group of investment professionals and staff, and we are dedicated to providing our team with the most opportunity for professional growth and impact, while working in a collaborative and inclusive environment.

Drunken Scotsman Extended, Julius Silver Scholarship Nyu, Ncaa Rules Coach Abuse, Dewitt County Judici, Articles G